• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>E.I. du Pont de Nemours & Company

E.I. du Pont de Nemours & Company

PowerShares Dynamic Pharmaceuticals ETF PJP 5 Star

Last Price$60.80Day Change (%)0.05%
Open Price$60.92Day Change ($)0.03
Day Range60.71–61.0452-Week Range53.55–69.24

As of Wed 2/22/2017 5:10:00 PM | USD

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. DuPont's stock surge helps push Dow industrials into positive territory

    DuPont's stock surge helps push Dow industrials into positive territory

  2. Dow, DuPont on Track for Merger Approval From EU Regulators -- Update

    Dow, DuPont on Track for Merger Approval From EU Regulators -- Update

  3. Global Baking Ingredients Market Report 2016-2022: Growing Number of People Shifting from Traditional Convenience Foods to Nutritive Convenience Foods - Research and Markets

    Global Baking Ingredients Market Report 2016-2022: Growing Number of People Shifting from Traditional Convenience Foods to Nutritive Convenience Foods - Research and Markets

  4. Global Protease Market to Reach $2.50 Billion by 2022: Increasing Demand From Both Domestic & Industrial Applications - Research and Markets

    Global Protease Market to Reach $2.50 Billion by 2022: Increasing Demand From Both Domestic & Industrial Applications - Research and Markets

  5. Global Lipase Market: Trends Analysis & Forecasts up to 2022 - Research and Markets

    Global Lipase Market: Trends Analysis & Forecasts up to 2022 - Research and Markets

  6. $19.15 Billion Printed Electronics Market (2014-2025) - Analysis By Material, Technology, Device, Region & Forecasts - Research and Markets

    $19.15 Billion Printed Electronics Market (2014-2025) - Analysis By Material, Technology, Device, Region & Forecasts - Research and Markets

  7. UPDATE: Chemours proves the bears wrong as stock climbs eightfold in a year

    UPDATE: Chemours proves the bears wrong as stock climbs eightfold in a year

  8. UPDATE: Chemours proves the bears wrong as stock climbs eightfold in a year

    UPDATE: Chemours proves the bears wrong as stock climbs eightfold in a year

  9. UPDATE: Chemours proves the bears wrong as stock climbs eightfold in a year

    UPDATE: Chemours proves the bears wrong as stock climbs eightfold in a year

  10. UPDATE: Chemours proves the bears wrong as stock climbs eightfold in a year

    UPDATE: Chemours proves the bears wrong as stock climbs eightfold in a year

12345

©2017 Morningstar Advisor. All right reserved.